RET-IN-25 (compound 6b) is a RET kinase inhibitor with anticancer activity. RET-IN-25 inhibits medullary thyroid carcinoma (MTC) with IC50s of 3.6 µM (3 days) and 3.0 µM (6 days) against TT(C634R) MTC[1].
Molecular Weight:
435.45
CAS Number:
[2965703-02-8]
Formula:
C22H17N3O5S
Target:
RET
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted